🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07067190
Starting soon Not applicable

Mandibular Implant Overdenture With OT Cap Bar vs Bar Attachment

NCT07067190 · tracked via the Priya Life Science Egypt tracker
Sponsor
Maisa Mohamed Farid Shaaban
Phase
Not applicable
Started
2026-09
Last updated
2026-03-18

Condition(s) studied

Edentulous MandibleImplant-Supported Overdentures

Investigational drug(s) / intervention(s)

Conventional Bar AttachmentBar with OT Cap Attachment

Conventional Bar Attachment: A rigid cast bar attachment fabricated and screwed onto three mandibular implants (placed at the midline and canine areas). The bar connects the implants to provide splinting and retention for a mandibular overdenture without the use of additional retentive components such as OT Caps. The overdenture is adjusted to fit passively over the bar and picked up intraorally.

Bar with OT Cap Attachment: A cast bar attachment fitted with two OT Cap attachments, which are designed to improve prosthesis retention and load distribution. This bar system is installed on three mandibular implants (midline and canine regions). The mandibular overdenture is relined to incorporate the female retentive caps that snap onto the OT Caps. This system combines the splinting benefits of the bar with the resilient retention of stud attachments.

Study summary

This clinical study is being conducted at Cairo University to evaluate two different types of attachments used with implant-supported dentures in the mandible. Patients who have lost all their teeth in the lower jaw receive implants to help hold their dentures in place. This study compares two types of attachments for connecting the denture to the implants:

1. Bar attachment only, which is a traditional method.
2. Bar with OT Cap attachment, which is a newer design that includes a small sphere (cap) to help with retention and comfort.

The purpose of this study is to find out which attachment type works better in terms of:

1. How well the denture stays in place (retention)
2. How much bone is lost around the implants over time (crestal bone loss)
3. How much the attachment parts wear out (cap wear)
4. How satisfied the patients are with their dentures

The study is a randomized controlled trial. This means participants will be randomly assigned to one of the two groups (bar-only or bar with OT Cap). All participants will receive complete dentures and three dental implants in the lower jaw.

Follow-up will include measurements of denture retention and cap wear at the time the denture is inserted and again after 6 months. Bone loss will be checked with digital X-rays, and patient satisfaction will be assessed using a short questionnaire.

The study will include 22 participants (11 in each group), aged 30 to 65, who are healthy and have enough bone in the jaw to support implants.

This study is designed to help dentists and patients make better decisions about which type of implant attachment provides better long-term results and patient comfort.

Eligibility

Sex
ALL
Min age
30 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Completely edentulous healthy patients * Age between 30 and 65 years * Adequate bone volume in the anterior and premolar-molar region (minimum 11 mm) * Adequate inter-arch space (12-14 mm) Exclusion Criteria: * Severe maxillomandibular skeletal discrepancy * Parafunctional habits (e.g., clenching, bruxism) * Temporomandibular joint disorders * Heavy smokers (≥20 cigarettes/day) * History of head and neck radiation * History of chemotherapy * Systemic conditions that may interfere with healing or bone quality (e.g., uncontrolled diabetes, osteoporosis, bisphosphonate therapy) * Drug abuse or alcohol dependence

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Oral and Dental Medicine, Cairo University Cairo Cairo Governorate

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07067190 on ClinicalTrials.gov ↗ ← All trials in Egypt